Africa: WHO Welcomes U.S.$ 250 Million NTD and Malaria Pledge By Novartis

24 June 2022
World Health Organization (Geneva)
press release

The World Health Organization (WHO) welcomes the announcement that Novartis pharmaceutical corporation will commit US$ 250 million to the fight against neglected tropical diseases (NTDs) and malaria. This comes in the wake of the Kigali Summit on Malaria and NTDs, which was held alongside the 26th Commonwealth Heads of Government meeting (CHOGM), on 23 June 2022.

The Kigali Declaration, announced at the event, aims to mobilize the political will and commitments required to achieve the United Nation's Sustainable Development Goal 3 (the "health goal"), which includes NTDs, and to deliver the targets set in WHO's NTD road map for 2021-2030.

The financial commitment announced by Novartis will help fund cutting-edge research and development, and will focus specifically on developing new, effective treatments for three NTDs (Chagas disease, dengue and visceral leishmaniasis), in addition to cryptosporidiosis and malaria.

WHO welcomes equally the commitment to partnership included in the investment, whereby Novartis will link with The Wellcome Trust, the Drugs for Neglected Diseases initiativeand other partners, to fight diseases which blight the lives of millions of people in some of the world's poorest communities.

Read the original article on WHO.

Tagged:
Copyright © 2022 World Health Organization. All rights reserved. Distributed by AllAfrica Global Media (allAfrica.com). To contact the copyright holder directly for corrections — or for permission to republish or make other authorized use of this material, click here.

AllAfrica publishes around 400 reports a day from more than 100 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.